Skip to content

Jia Wei Bai Zhu Formulae for the treatment of constipation in patients in the recovery phase of cerebral infarction: a randomized controlled clinical study.

Jia Wei Bai Zhu Formulae for the treatment of constipation in patients in the recovery phase of cerebral infarction: a randomized controlled clinical study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002472
Enrollment
Unknown
Registered
2025-12-24
Start date
2025-12-31
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke constipation

Interventions

Experimental Group:Jia Wei Bai Zhu Formulae

Sponsors

Shunyi Hospital, Beijing Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients who meet the diagnostic criteria for stroke and constipation in both TCM and Western medicine, as well as the TCM diagnostic criteria for syndrome differentiation, and have constipation occurring after stroke. (2) Patients aged 35-75 years, with no restriction on gender. (3) Patients who have not taken any constipation-related medications in the 3 days prior to treatment (excluding emergency medications: glycerin suppositories), and have not received any measures related to the treatment of this condition, such as acupuncture injection, acupoint application, or Chinese herbal enema. (4) Patients with a stroke duration of more than 14 days and less than 6 months. (5) Patients who are conscious, have normal comprehension ability, no communication barriers, and can cooperate with scale assessments, and have signed an informed consent form (patients unable to sign due to physical disabilities, etc., may have their family members sign on their behalf).

Exclusion criteria

Exclusion criteria: (1) History of severe gastrointestinal-related diseases, such as digestive tract tumors, severe enteritis, intestinal obstruction, and severe primary diseases of the heart, liver, lungs, kidneys, endocrine system, or hematopoietic system; (2) Presence of clear surgical indications for gastrointestinal conditions; (3) Patients with other brain diseases such as encephalitis, epilepsy, or other cerebrovascular diseases such as moyamoya disease or venous sinus thrombosis; (4) Hypokalemic ileus; (5) Allergic constitution or allergy to drugs used in this study; (6) Patients with impaired consciousness, cognitive impairment, mental illness, or other reasons that prevent cooperation with relevant assessments, examinations, or treatments; (7) Participants who were involved in other clinical trials within 1 week prior to enrollment; (8) Pregnant, breastfeeding, or women planning to become pregnant.

Design outcomes

Primary

MeasureTime frame
Wexner Constipation Scoring;

Secondary

MeasureTime frame
Average weekly frequency of complete spontaneous bowel movements.;Application frequency and quantity of glycerin suppositories during the intervention period.;Bristol Stool Scale;NIHSS score;Daily life can be rated.;Traditional Chinese Medicine Syndrome Scoring Scale;

Countries

China

Contacts

Public Contactchenhuan

Shunyi Hospital, Beijing Hospital of Traditional Chinese Medicine

18801126817@163.com18801126817

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026